5441842026-01-012026-03-315441842026-03-315441842025-03-315441842025-04-012026-03-315441842026-01-012026-03-31in-capmkt:OtherExpenses1Member5441842025-04-012026-03-31in-capmkt:OtherExpenses1Member5441842026-03-31OtherNoncurrentFinancialAssetsDomain15441842026-03-31OtherNoncurrentAssetsDomain15441842026-03-31OtherNoncurrentAssetsDomain25441842026-03-31OtherCurrentFinancialAssetsDomain15441842026-03-31OtherCurrentAssetsDomain15441842026-03-31OtherNoncurrentFinancialLiabilitiesDomain15441842026-03-31OtherCurrentFinancialLiabilitiesDomain15441842026-03-31OtherCurrentLiabilitiesDomain15441842026-01-012026-03-31in-capmkt:ReportableSegments1Member5441842026-01-012026-03-31in-capmkt:ReportableSegments2Member5441842026-01-012026-03-31in-capmkt:ReportableSegments3Member5441842025-04-012026-03-31in-capmkt:ReportableSegments1Member5441842025-04-012026-03-31in-capmkt:ReportableSegments2Member5441842025-04-012026-03-31in-capmkt:ReportableSegments3Member5441842026-01-012026-03-31in-capmkt:ReportableSegments1Member5441842026-01-012026-03-31in-capmkt:ReportableSegments2Member5441842026-01-012026-03-31in-capmkt:ReportableSegments3Member5441842025-04-012026-03-31in-capmkt:ReportableSegments1Member5441842025-04-012026-03-31in-capmkt:ReportableSegments2Member5441842025-04-012026-03-31in-capmkt:ReportableSegments3Member5441842026-01-012026-03-31in-capmkt:ReportableSegments1Member5441842026-03-31in-capmkt:ReportableSegments1Member5441842026-01-012026-03-31in-capmkt:ReportableSegments2Member5441842026-03-31in-capmkt:ReportableSegments2Member5441842026-01-012026-03-31in-capmkt:ReportableSegments3Member5441842026-03-31in-capmkt:ReportableSegments3Member5441842026-01-012026-03-31in-capmkt:ReportableSegments1Member5441842026-03-31in-capmkt:ReportableSegments1Member5441842026-01-012026-03-31in-capmkt:ReportableSegments2Member5441842026-03-31in-capmkt:ReportableSegments2Member5441842026-01-012026-03-31in-capmkt:ReportableSegments3Member5441842026-03-31in-capmkt:ReportableSegments3Member5441842026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15441842025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15441842026-01-012026-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544184BOROSCINOTLISTEDINE02L001032BOROSIL SCIENTIFIC LIMITEDMain BoardEquity2025-04-012026-03-312026-05-202026-05-13INRLakhsQuarterlyFourth quarterMulti segment2026-05-2012:50:002026-05-2014:35:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated143168700020627000145231400044466500029896000257300001793650002626000476220004309500001160854000291460000029146000073808000-548070001900100002724590000000272459000-2120002722470002720990003600002718540003930008894700013.063.06003.063.06000 <BR> Notes on Audited Consolidated Financial Results for the quarter and year ended 31st March, 2026: <BR> <BR> 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held o¬n 20th May, 2026. <BR> <BR> 2. Pursuant to exercise of the options issued under “Borosil Scientific Limited - Special Purpose Employee Stock Option Plan 2023”, the Company has made allotment of Nil Equity Shares and 13,747 Equity Shares, respectively of the face value of Re. 1/- each for the quarter and year ended 31st March, 2026, which has resulted into increase of paid up Equity Share Capital by Nil and Rs. 0.14 lakhs, respectively and Securities Premium by Nil and Rs. 15.14 lakhs, respectively. <BR> <BR> 3. As informed earlier, the Company had introduced a Voluntary Retirement Scheme (VRS) for the eligible workers at its plant situated at Village Ambad, Nashik, Maharashtra . During the first quarter, the Company entered into a Memorandum of Settlement, with the Bhartiya Kamgar Sena (BKS), outlining the terms of final settlement under VRS. BKS is a trade union registered under Trade Union’s Act, 1926, representing the said eligible workers. The above settlement resulted total expenditure of Rs. 661.31 lakhs (including professional fees related to the above) for year ended 31st March, 2026 and shown as an exceptional item in the above results. <BR> <BR> 4. As Informed earlier, Effective from 21st November, 2025, the Government of India has consolidated 29 existing labour legislations into a united framework comprising four Labour Codes. On the basis of best available information, the Company has assessed the one time incremental impact of Rs. 191.51 lakhs for the quarter ended 31st December 2025 and for the year ended 31st March, 2026 and disclosed as an exceptional item in the above results. The Company continues to monitor the finalisation of Central / State Government Rules and clarifications in relation to newly introduced Labour Code and would provide appropriate accounting effect on the basis of new developments, if required. <BR> <BR> 5. The figures for the corresponding previous period/year have been rearranged/ regrouped, wherever necessary, to make them comparable. The figures for the quarter ended 31st March, 2026 and 31st March, 2025 are the balancing figures between the audited figures of the full financial year and the published year to date figures upto the third quarter of the respective financial year. <BR> <BR> <BR> For Borosil Scientific Limited <BR> <BR> <BR> <BR> <BR> Place: Mumbai Vinayak Patankar <BR> Date : 20th May, 2026 Whole-time Director & CEO <BR> (DIN 07534225) <BR> 2025-04-012026-03-31AuditedConsolidated46734150009545900047688740001584399000112858000-288440008020380001128000019238800015810270004255146000513728000-85282000428446000144135000-615010008263400003458120000000345812000-300000345512000346136000-324000345809000-29700088947000142142960003.893.89003.893.89000Other Expenses430950000Other Expenses158102700012163070008777000006219370004731000031600000141000084000023856000248370001020790003624100021367970001032487000122439200075726300013178200056780005464000595560002184135000480000136927000335402900000549082600088947000432412500044130720001854000441492600076720000005737000134090004060400094081000014809400072889000133873000291005000424878000221249000719016000112581000858480001036100009278060000010759000005490826000Others23856000Other non-current assets32824000Non Current Tax Assets(Net)3417000Others59556000Other current assets136927000Lease liabilities5737000Other Financial liabilities221249000Other current liabilities112581000Scientific-Laboratory Glass and Equipment and process system1096075000Glassware317558000Others18054000Scientific-Laboratory Glass and Equipment and process system3309296000Glassware1307931000Others56188000143168700046734150000014316870004673415000Scientific-Laboratory Glass and Equipment and process system340612000Glassware-16333000Others4870000Scientific-Laboratory Glass and Equipment and process system754417000Glassware-110380000Others2058900032914900066462600026260001128000035063000224900000291460000428446000Scientific-Laboratory Glass and Equipment and process system2131531000Glassware1219140000Others35094000338576500021050610005490826000Scientific-Laboratory Glass and Equipment and process system626775000Glassware243900000Others53360008760110001998890001075900000Note : <BR> <BR> As per Indian Accounting Standard 108 on ‘Operating Segment’ (Ind-AS 108), the Group has reported "Segment information", as described below: <BR> <BR> Scientific – Laboratory Glass & equipment and Process System:- Comprising of items used in laboratories, production floor and research and development <BR> Glassware:- pharmaceutical primary packaging and domestic glassware items <BR> Others :- Comprising of Filter Paper etc. <BR> Unallocated:- Consists of income, expenses, assets and liabilities which can not be directly identified to any of the above segments.11280000-67151000-516760000211350000000768210000529600001923880000000012770000272600021682000-638500000-63590000932100001474380005758840000001431840000432700000002900000003900000000000919800028452500000000000000000000033540000-177000-372150000000000152800000607240004127000011447000012766000-62004000-1454000-1000-1455000133237000131782000Re-measurement gains/(losses)on defined before paims-284000-284000Re-measurement gains/(losses)on defined before paims-401000-401000-72000-10100000-212000-300000AuditedtrueM/s. Chaturvedi & Shah LLPtrue2026-06-30